MPM BioVentures III discloses amended 9.5% stake - 13D/A filing Effective September 27, 2016, the reporting persons distributed an aggregate of 1,943,751 shares of the Issuers Common Stock to their respective limited partners and members on a pro rata basis for no additional consideration.